Bioventus (BVS) Non Operating Income (2020 - 2026)

Bioventus (BVS) has 7 years of Non Operating Income data on file, last reported at $427000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 105.15% year-over-year to $427000.0; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (up 139.29% YoY), and the FY2025 full-year result was -$1.5 million, up 96.09% from the prior year.
• Non Operating Income for Q1 2026 stood at $427000.0, down from $21.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $21.5 million in Q4 2025 and bottomed at -$16.8 million in Q4 2022.
• The 5-year median for Non Operating Income is -$8.1 million (2023), against an average of -$5.1 million.
• The widest annual swing landed in 2022, when Non Operating Income soared 556.56%; it then plunged 9125.22% in 2023.
• A 5-year view of Non Operating Income shows it stood at -$16.8 million in 2022, then surged by 43.04% to -$9.6 million in 2023, then rose by 18.96% to -$7.8 million in 2024, then surged by 376.81% to $21.5 million in 2025, then slumped by 98.01% to $427000.0 in 2026.
• The last three Non Operating Income figures came in at $427000.0 (Q1 2026), $21.5 million (Q4 2025), and -$79000.0 (Q3 2025), per Business Quant data.

Peer Comparison